Navigation Links
Leprosy Genes Identified
Date:12/16/2009

Scientists pinpoint seven that increase susceptibility to disease

WEDNESDAY, Dec. 16 (HealthDay News) -- Seven genes associated with increased susceptibility to leprosy have been identified by scientists in Singapore and China.

The researchers, who analyzed more than 10,000 DNA samples from leprosy patients and healthy people in China, said their discovery highlights the important role that the innate immune response plays in the development of leprosy.

"Though leprosy is not common, the discoveries have significant ramifications for chronic infectious disorders and for host-pathogen interactions in other more prevalent mycobacterial diseases such as tuberculosis," Dr. Edison Liu, executive director of the Genome Institute of Singapore, said in a news release from the institute.

"The discovery of these genes is a major breakthrough for research in leprosy and infectious diseases in general, and will be significant in the early diagnosis and development of new treatments," study co-leader Jianjun Liu, Human Genetics Group Leader at the institute, said in the release.

The study appears online Dec. 16 in the New England Journal of Medicine.

The genes are: CCDC122, C13orf31, NOD2, TNFSF15, HLA-DR, RIPK2 and LRRK2.

Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae. The disease, which mainly affects skin and peripheral nerves, is rare in developed countries, but remains a major public health problem in many developing countries. According to the World Health Organization, 254,525 new cases of leprosy were diagnosed in 2007.

In regions where leprosy is common, many people are exposed but only a few become infected and develop clinical signs of leprosy, which indicates that only certain people are susceptible to the disease.

More information

The U.S. National Library of Medicine has more about leprosy.



-- Robert Preidt



SOURCES: Agency for Science, Technology and Research, Singapore, news release, Dec. 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New York Community Trust Awards Grant of $100,000 to Infectious Disease Research Institute for Early Detection Leprosy Tests
2. Forgotten, but not gone: Leprosy still present in the US
3. Researchers identify new leprosy bacterium
4. Leprosy Lingers in the U.S.
5. Local Web Design Agency Launches Leprosy Charity Website for Women in Need
6. DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy
7. Pathway links inflammation, angiogenesis and breast cancer
8. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
9. New Database to Help Speed Search for Bipolar Disorder Genes
10. Is Perfect Pitch All in the Genes?
11. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology: